Observational Data Collection for Parkinson's (NCT07386015)

Track freezing of gait progression

Trial ID
NCT07386015
Official Title
FREEZE-Path Cohort: Etiology-Phenotype-Outcome Pathway Study on Freezing of Gait (FOG)
Goal
Track freezing of gait progression
Status
RECRUITING
Sponsor
Tianjin Huanhu Hospital
Study Type
OBSERVATIONAL
Enrollment
700 participants
Conditions
Freezing of Gait, Parkinson's Disease, Parkinsonism, Vascular Parkinsonism, Idiopathic Normal Pressure Hydrocephalus (INPH)
Interventions
Observational Data Collection

Summary For Families

Freeze-Path is building a long-term patient registry to learn more about freezing of gait, the sudden trouble starting or keeping walking that leads to falls, loss of independence, and reduced quality of life. Participants receive their usual medical care while researchers collect information over up to 36 months during routine visits, using questionnaires, walking and balance tests, video recordings, and other common clinical assessments, and no experimental drugs or treatments are given. Adults aged 30 to 85 with freezing of gait or other gait and balance problems and a diagnosis of Parkinson's disease or a related condition can join if they can complete the walking and balance tasks (with help if needed) and can give written consent; people with very severe dementia, recent major medical events, serious psychiatric or medical problems that affect walking safety, or who refuse video or speech recording are not eligible.

Locations

  • Tianjin Huanhu Hospital, Tianjin, Tianjin Municipality, China

Frequently Asked Questions

What is this trial testing?
This trial is studying Observational Data Collection. Freeze-Path is building a long-term patient registry to learn more about freezing of gait, the sudden trouble starting or keeping walking that leads to falls, loss of independence, and reduced quality of life. Participants receive their usual medical care while researchers collect information over up to 36 months during routine visits, using questionnaires, walking and balance tests, video recordings, and other common clinical assessments, and no experimental drugs or treatments are given. Adults aged 30 to 85 with freezing of gait or other gait and balance problems and a diagnosis of Parkinson's disease or a related condition can join if they can complete the walking and balance tasks (with help if needed) and can give written consent; people with very severe dementia, recent major medical events, serious psychiatric or medical problems that affect walking safety, or who refuse video or speech recording are not eligible.
Who can participate?
Participants must be between 30 Years and 85 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 3 years and 10 months.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
This is an observational study, so there is no placebo and no experimental treatment is assigned. Researchers observe and collect information while you continue your usual care.
How many visits does this trial involve?
You will have clinical assessments at baseline and during scheduled follow-up visits over a planned follow-up period of up to 36 months.
What procedures are involved in this trial?
Based on the protocol, this trial involves: Questionnaires & surveys (non-invasive). Confirm the full schedule with the study coordinator.

Related Reading

View on ClinicalTrials.gov